XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statement of Changes in Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Cumulative change in accounting principal for adoption
Common Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative change in accounting principal for adoption
Accumulated Other Comprehensive Income (loss)
Balance at beginning of period (shares) at Dec. 31, 2021     10,502,442        
Balance at beginning of period at Dec. 31, 2021 $ 170,866   $ 105 $ 119,925 $ 50,675   $ 161
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 4,706       4,706    
Other comprehensive income (loss), net of tax (7,123)           (7,123)
Surrender of restricted shares of common stock (shares)     (10,119)        
Surrender of restricted shares of common stock (141)     (141)      
Restricted common stock awarded under the equity incentive plan (shares)     38,586        
Restricted common stock issued upon achievement (in shares)     11,834        
Amortization of restricted stock 195     195      
Cash dividends (2,742)       (2,742)    
Common stock options exercised (shares)     2,500        
Common stock options exercised 20     20      
Common stock repurchased (shares)     (18,462)        
Common stock repurchased (288)     (211) (77)    
Stock option expense 1     1      
Balance at end of period (shares) at Mar. 31, 2022     10,526,781        
Balance at end of period at Mar. 31, 2022 165,494   $ 105 119,789 52,562   (6,962)
Balance at beginning of period (shares) at Dec. 31, 2021     10,502,442        
Balance at beginning of period at Dec. 31, 2021 $ 170,866   $ 105 119,925 50,675   161
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock options exercised (shares) 7,900            
Balance at end of period (shares) at Dec. 31, 2022     10,425,119        
Balance at end of period at Dec. 31, 2022 $ 167,088   $ 104 119,240 65,400   (17,656)
Balance at end of period (Accounting Standards Update 2016-13) at Dec. 31, 2022   $ (4,432)       $ (4,432)  
Balance at end of period (Accounting Standards Update 2023-02) at Dec. 31, 2022   130       130  
Balance at beginning of period (shares) at Mar. 31, 2022     10,526,781        
Balance at beginning of period at Mar. 31, 2022 165,494   $ 105 119,789 52,562   (6,962)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 4,366       4,366    
Other comprehensive income (loss), net of tax (5,315)           (5,315)
Forfeiture of unvested shares (shares)     (866)        
Restricted common stock awarded under the equity incentive plan (shares)     4,500        
Amortization of restricted stock 197     197      
Stock option expense 1     1      
Balance at end of period (shares) at Jun. 30, 2022     10,530,415        
Balance at end of period at Jun. 30, 2022 164,743   $ 105 119,987 56,928   (12,277)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 3,993       3,993    
Other comprehensive income (loss), net of tax (4,980)           (4,980)
Forfeiture of unvested shares (shares)     (1,260)        
Surrender of restricted shares of common stock (shares)     (120)        
Surrender of restricted shares of common stock (2)     (2)      
Restricted common stock awarded under the equity incentive plan (shares)     2,136        
Amortization of restricted stock 255     255      
Common stock repurchased (shares)     (52,961)        
Common stock repurchased (691)   $ 0 (603) (88)    
Stock option expense 1     1      
Balance at end of period (shares) at Sep. 30, 2022     10,478,210        
Balance at end of period at Sep. 30, 2022 163,319   $ 105 119,638 60,833   (17,257)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 4,696       4,696    
Other comprehensive income (loss), net of tax (399)           (399)
Forfeiture of unvested shares (shares)     (500)        
Surrender of restricted shares of common stock (shares)     (491)        
Surrender of restricted shares of common stock (7)     (7)      
Amortization of restricted stock 213     213      
Common stock options exercised (shares)     5,400        
Common stock options exercised 51   $ 0 51      
Common stock repurchased (shares)     (57,500)        
Common stock repurchased (785)   $ (1) (655) (129)    
Balance at end of period (shares) at Dec. 31, 2022     10,425,119        
Balance at end of period at Dec. 31, 2022 167,088   $ 104 119,240 65,400   (17,656)
Balance at end of period (Accounting Standards Update 2016-13) at Dec. 31, 2022   (4,432)       (4,432)  
Balance at end of period (Accounting Standards Update 2023-02) at Dec. 31, 2022   130       $ 130  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 3,662       3,662    
Net income | Accounting Standards Update 2023-02   $ 32          
Other comprehensive income (loss), net of tax 1,065           1,065
Forfeiture of unvested shares (shares)     (1,168)        
Surrender of restricted shares of common stock (shares)     (10,287)        
Surrender of restricted shares of common stock (129)     (129)      
Restricted common stock awarded under the equity incentive plan (shares)     50,606        
Restricted common stock awarded under the equity incentive plan 1   $ 1        
Restricted common stock issued upon achievement (in shares)     18,551        
Amortization of restricted stock 216     216      
Cash dividends $ (3,040)       (3,040)    
Common stock options exercised (shares) 0            
Balance at end of period (shares) at Mar. 31, 2023     10,482,821        
Balance at end of period at Mar. 31, 2023 $ 164,561   $ 105 $ 119,327 $ 61,720   $ (16,591)